How to manage radiation-induced dermatitis?

Dorota Kiprian, Agata Szykut-Badaczewska, Agnieszka Gradzińska, Joanna Czuwara, Lidia Rudnicka

Vol 72, No 2 (2022)

Review paper

Off-label use of medicinal products in oncology: exercising due diligence or experimental activity?

Justyna Estera Król-Całkowska, Janusz Jaroszyński

Vol 72, No 1 (2022)

Review paper

Recommendations of the Polish Sarcoma Group on diagnostic-therapeutic procedures and control in patients with type 1 neurofibromatosis (NF1) and the associated malignant neoplasm of peripheral nerve sheaths

Piotr Rutkowski, Anna Raciborska, Anna Szumera-Ciećkiewicz, Paweł Sobczuk, Mateusz Spałek, Hanna Koseła-Paterczyk, Iwona Ługowska, Katarzyna Bilska, Monika Gos, Janusz Ryś, Ewa Chmielik, Andrzej Tysarowski, Konrad Zaborowski, Małgorzata Oczko-Wojciechowska, Patrycja Castaneda-Wysocka, Donata Makuła, Marcin Zdzienicki, Marcin Ziętek, Piotr Fonrobert, Kamil Dolecki, Marek Dedecjus, Anna M. Czarnecka

Vol 72, No 2 (2022)

Guidelines / Expert consensus

Consensus on methods of development of clinical practice guidelines in oncology under the auspices of Maria Sklodowska-Curie National Research Institute of Oncology and the Agency for Health Technology Assessment and Tariff System

Jan Walewski, Dominik Dziurda, Mariusz Bidziński, Barbara Bobek-Bilewicz, Marek Dedecjus, Iwona Hus, Beata Jagielska, Jacek Jassem, Andrzej Kawecki, Dariusz Kowalski, Magdalena Krasztel, Maciej Krzakowski, Tomasz Kubiatowski, Piotr Potemski, Radosław Mądry, Piotr Rutkowski, Anna Rychert, Janusz Ryś, Krzysztof Składowski, Rafał Tarnawski, Hanna Tchórzewska-Korba, Andrzej Tysarowski, Piotr J. Wysocki, Roman Topór-Mądry

Vol 72, No 1 (2022)

Guidelines / Expert consensus

Secondary prevention and treatment of cervical cancer – an update from Poland

Patryk Poniewierza, Marcin Śniadecki, Michał Brzeziński, Dagmara Klasa-Mazurkiewicz, Grzegorz Panek

Vol 72, No 1 (2022)

Research paper (original)

The Poly(ADP-ribose) polymerase inhibitors in pancreatic cancer

Katarzyna Zubik, Julia Talaśka, Dawid Sigorski, Sergiusz Nawrocki

Vol 72, No 1 (2022)

Review paper

Phacomatoses, genetic testing for personalisation of clinical management (part 2)

Anna Kofla-Dłubacz, Andrzej Stawarski, Tomasz Pytrus, Justyna Gil

Vol 72, No 1 (2022)

Review paper

Hepatocellular cancer and colorectal liver metastasis treatment in the older population

Jakub Kenig

Vol 72, No 1 (2022)

Review paper

Selected platinum complexes in standard and modern anti-cancer therapies

Anna Kopacz-Bednarska, Teodora Król

Vol 72, No 2 (2022)

Review paper

Dose estimation in patients treated with radiotherapy for SARS-COVID disease based on EPID measurement

Krzysztof Ślosarek, Tomasz Rutkowski, Adam Gądek, Łukasz Sroka, Łukasz Dolla, Roman Rutkowski, Jerzy Jaroszkiewicz

Vol 72, No 2 (2022)

Research paper (original)

Does the culture of science publishing need to change from the status quo principle of “trust me”?

Jaime A. Teixeira da Silva

Vol 72, No 2 (2022)

Letter to the Editor

The prognostic value of RDW, NLR and PLR in sequential radio-chemotherapy for advanced lung cancer

Iwona Jabłońska, Marcin Miszczyk, Marcin Goławski, Iwona Dębosz-Suwińska, Rafał Suwiński

Vol 72, No 3 (2022)

Research paper (original)

Sexual Health in breast cancer patients in Poland

Joanna Kufel-Grabowska, Milena Lachowicz, Mikołaj Bartoszkiewicz, Rodryg Ramlau, Daniel Maliszewski, Krzysztof Łukaszuk

Vol 72, No 2 (2022)

Research paper (original)

Selected syndromes of hamartomatous polyposis of the gastrointestinal tract – clinical and genetic aspects

Tomasz Pytrus, Karolina Pesz, Anna Kofla-Dlubacz, Andrzej Stawarski, Justyna Gil

Vol 72, No 2 (2022)

Review paper

Possibilities of applying a combination of targeted molecular therapies and immunotherapy in NSCLC patients

Magdalena Wójcik-Superczyńska, Tomasz Jankowski, Paweł Krawczyk

Vol 72, No 3 (2022)

Review paper